Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

~20 mi. (Aberdeen, United Kingdom, +159 more cities)

Aberdeen Royal Infirmary ( Site 0708)

Superficial Bladder Urothelial Carcinoma

cisplatin, +2 more drugs

chemotherapy, +1 more type

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~20 mi. (Aberdeen, United Kingdom, +122 more cities)

Royal Infirmary Aberdeen ( Site 2403)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~20 mi. (Aberdeen, United Kingdom, +202 more cities)

Site GB44003

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

~20 mi. (Aberdeen, United Kingdom, +127 more cities)

Aberdeen Royal Infirmary ( Site 2905)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~20 mi. (Aberdeen, United Kingdom, +126 more cities)

Aberdeen Royal Infirmary ( Site 0474)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

~20 mi. (Aberdeen, United Kingdom, +79 more cities)

Aberdeen Royal Infirmary

Mantle Cell Lymphoma

pirtobrutinib

targeted therapy

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

~20 mi. (Aberdeen, United Kingdom, +70 more cities)

Aberdeen Royal Infirmary ( Site 0911)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With CLL or SLL

~20 mi. (Aberdeen, United Kingdom, +71 more cities)

Aberdeen Royal Infirmary

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

pirtobrutinib

targeted therapy

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

~20 mi. (Aberdeen, United Kingdom, +52 more cities)

Investigational Site

Colorectal Adenocarcinoma

AB680, +4 more drugs

chemotherapy, +2 more types

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

~20 mi. (Aberdeen, United Kingdom, +47 more cities)

Novartis Investigative Site

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

bevacizumab, +6 more drugs

chemotherapy, +2 more types

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

~20 mi. (Aberdeen, United Kingdom, +2 more cities)

Aberdeen Royal Informary

CDKN2A Overexpression, +1 more biomarker

Anal Squamous Cell Carcinoma

chemoradiotherapy, +1 more drug

chemotherapy, +2 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~95 mi. (Dundee, United Kingdom, +131 more cities)

Ninewells Hospital and Medical School ( Site 2207)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types